{"text_format":"3","workbook":"xls","n_sheets":5,"sheets":["Canonical Pathways","Functions and disease","Specific functions","Tox functions","Networks"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Canonical Pathways","index":0,"n_rows":94,"n_cols":4,"rows_kept":94,"flags":["formulas_cached_only"]}
["© 2000-2016 QIAGEN. All rights reserved."]
["Ingenuity Canonical Pathways"," -log(p-value)","Ratio","Molecules"]
["Remodeling of Epithelial Adherens Junctions",{"v":6.97,"d":"6.97E+00"},{"v":0.0735,"d":"7.35E-02"},"ACTR2.ARPC2.ACTB.TUBB.ACTG1"]
["Signaling by Rho Family GTPases",{"v":5.55,"d":"5.55E+00"},{"v":0.0254,"d":"2.54E-02"},"STMN1.ACTR2.ARPC2.ACTB.VIM.ACTG1"]
["Epithelial Adherens Junction Signaling",{"v":5.28,"d":"5.28E+00"},{"v":0.0338,"d":"3.38E-02"},"ACTR2.ARPC2.ACTB.TUBB.ACTG1"]
["RhoGDI Signaling",{"v":4.88,"d":"4.88E+00"},{"v":0.0279,"d":"2.79E-02"},"ACTR2.ARPC2.ACTB.ACTG1.ARHGDIB"]
["Clathrin-mediated Endocytosis Signaling",{"v":4.78,"d":"4.78E+00"},{"v":0.0266,"d":"2.66E-02"},"ACTR2.ALB.ARPC2.ACTB.ACTG1"]
["Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes",{"v":4.61,"d":"4.61E+00"},{"v":0.0404,"d":"4.04E-02"},"ACTR2.ARPC2.ACTB.ACTG1"]
["RhoA Signaling",{"v":4.23,"d":"4.23E+00"},{"v":0.0323,"d":"3.23E-02"},"ACTR2.ARPC2.ACTB.ACTG1"]
["Caveolar-mediated Endocytosis Signaling",{"v":3.58,"d":"3.58E+00"},{"v":0.0411,"d":"4.11E-02"},"ALB.ACTB.ACTG1"]
["ILK Signaling",{"v":3.54,"d":"3.54E+00"},{"v":0.0214,"d":"2.14E-02"},"PPP2CB.ACTB.VIM.ACTG1"]
["Integrin Signaling",{"v":3.36,"d":"3.36E+00"},{"v":0.0192,"d":"1.92E-02"},"ACTR2.ARPC2.ACTB.ACTG1"]
["Death Receptor Signaling",{"v":3.28,"d":"3.28E+00"},{"v":0.0326,"d":"3.26E-02"},"ACTB.ACTG1.ARHGDIB"]
["Actin Cytoskeleton Signaling",{"v":3.27,"d":"3.27E+00"},{"v":0.0182,"d":"1.82E-02"},"ACTR2.ARPC2.ACTB.ACTG1"]
["Regulation of Actin-based Motility by Rho",{"v":3.27,"d":"3.27E+00"},{"v":0.0323,"d":"3.23E-02"},"ACTR2.ARPC2.ACTB"]
["Mechanisms of Viral Exit from Host Cells",{"v":2.65,"d":"2.65E+00"},{"v":0.0488,"d":"4.88E-02"},"ACTB.ACTG1"]
["Germ Cell-Sertoli Cell Junction Signaling",{"v":2.57,"d":"2.57E+00"},{"v":0.0184,"d":"1.84E-02"},"ACTB.TUBB.ACTG1"]
["Tight Junction Signaling",{"v":2.54,"d":"2.54E+00"},{"v":0.018,"d":"1.80E-02"},"PPP2CB.ACTB.ACTG1"]
["MSP-RON Signaling Pathway",{"v":2.53,"d":"2.53E+00"},{"v":0.0426,"d":"4.26E-02"},"ACTB.ACTG1"]
["Gap Junction Signaling",{"v":2.53,"d":"2.53E+00"},{"v":0.0179,"d":"1.79E-02"},"ACTB.TUBB.ACTG1"]
["Sertoli Cell-Sertoli Cell Junction Signaling",{"v":2.4,"d":"2.40E+00"},{"v":0.0161,"d":"1.61E-02"},"ACTB.TUBB.ACTG1"]
["Role of CHK Proteins in Cell Cycle Checkpoint Control",{"v":2.4,"d":"2.40E+00"},{"v":0.0364,"d":"3.64E-02"},"PPP2CB.PCNA"]
["Actin Nucleation by ARP-WASP Complex",{"v":2.38,"d":"2.38E+00"},{"v":0.0357,"d":"3.57E-02"},"ACTR2.ARPC2"]
["Breast Cancer Regulation by Stathmin1",{"v":2.33,"d":"2.33E+00"},{"v":0.0152,"d":"1.52E-02"},"STMN1.PPP2CB.TUBB"]
["Agrin Interactions at Neuromuscular Junction",{"v":2.19,"d":"2.19E+00"},{"v":0.0286,"d":"2.86E-02"},"ACTB.ACTG1"]
["Protein Ubiquitination Pathway",{"v":2.01,"d":"2.01E+00"},{"v":0.0116,"d":"1.16E-02"},"PSMB7.PSMB10.HSPD1"]
["Crosstalk between Dendritic Cells and Natural Killer Cells",{"v":1.98,"d":"1.98E+00"},{"v":0.0222,"d":"2.22E-02"},"ACTB.ACTG1"]
["FAK Signaling",{"v":1.98,"d":"1.98E+00"},{"v":0.0222,"d":"2.22E-02"},"ACTB.ACTG1"]
["Virus Entry via Endocytic Pathways",{"v":1.94,"d":"1.94E+00"},{"v":0.0211,"d":"2.11E-02"},"ACTB.ACTG1"]
["VEGF Signaling",{"v":1.91,"d":"1.91E+00"},{"v":0.0204,"d":"2.04E-02"},"ACTB.ACTG1"]
["Paxillin Signaling",{"v":1.89,"d":"1.89E+00"},{"v":0.0198,"d":"1.98E-02"},"ACTB.ACTG1"]
["Formaldehyde Oxidation II (Glutathione-dependent)",{"v":1.87,"d":"1.87E+00"},{"v":0.125,"d":"1.25E-01"},"ESD"]
["Rac Signaling",{"v":1.84,"d":"1.84E+00"},{"v":0.0187,"d":"1.87E-02"},"ACTR2.ARPC2"]
["fMLP Signaling in Neutrophils",{"v":1.78,"d":"1.78E+00"},{"v":0.0174,"d":"1.74E-02"},"ACTR2.ARPC2"]
["Pyruvate Fermentation to Lactate",{"v":1.77,"d":"1.77E+00"},"1E-01","LDHB"]
["14-3-3-mediated Signaling",{"v":1.75,"d":"1.75E+00"},{"v":0.0168,"d":"1.68E-02"},"VIM.TUBB"]
["CD28 Signaling in T Helper Cells",{"v":1.73,"d":"1.73E+00"},{"v":0.0163,"d":"1.63E-02"},"ACTR2.ARPC2"]
["phagosome maturation",{"v":1.7,"d":"1.70E+00"},{"v":0.0157,"d":"1.57E-02"},"TUBB.PRDX2"]
["BER pathway",{"v":1.66,"d":"1.66E+00"},{"v":0.0769,"d":"7.69E-02"},"PCNA"]
["Galactose Degradation I (Leloir Pathway)",{"v":1.62,"d":"1.62E+00"},{"v":0.0714,"d":"7.14E-02"},"GALM"]
["Cellular Effects of Sildenafil (Viagra)",{"v":1.61,"d":"1.61E+00"},{"v":0.0141,"d":"1.41E-02"},"ACTB.ACTG1"]
["Mismatch Repair in Eukaryotes",{"v":1.52,"d":"1.52E+00"},{"v":0.0556,"d":"5.56E-02"},"PCNA"]
["Tec Kinase Signaling",{"v":1.51,"d":"1.51E+00"},{"v":0.0125,"d":"1.25E-02"},"ACTB.ACTG1"]
["GADD45 Signaling",{"v":1.49,"d":"1.49E+00"},{"v":0.0526,"d":"5.26E-02"},"PCNA"]
["Sucrose Degradation V (Mammalian)",{"v":1.49,"d":"1.49E+00"},{"v":0.0526,"d":"5.26E-02"},"GALM"]
["Cdc42 Signaling",{"v":1.47,"d":"1.47E+00"},{"v":0.0118,"d":"1.18E-02"},"ACTR2.ARPC2"]
["Ephrin Receptor Signaling",{"v":1.43,"d":"1.43E+00"},{"v":0.0113,"d":"1.13E-02"},"ACTR2.ARPC2"]
["NRF2-mediated Oxidative Stress Response",{"v":1.42,"d":"1.42E+00"},{"v":0.0111,"d":"1.11E-02"},"ACTB.ACTG1"]
["Axonal Guidance Signaling",{"v":1.41,"d":"1.41E+00"},{"v":0.00682,"d":"6.82E-03"},"ACTR2.ARPC2.TUBB"]
["Production of Nitric Oxide and Reactive Oxygen Species in Macrophages",{"v":1.39,"d":"1.39E+00"},{"v":0.0108,"d":"1.08E-02"},"PPP2CB.ALB"]
["Agranulocyte Adhesion and Diapedesis",{"v":1.38,"d":"1.38E+00"},{"v":0.0105,"d":"1.05E-02"},"ACTB.ACTG1"]
["AMPK Signaling",{"v":1.36,"d":"1.36E+00"},{"v":0.0103,"d":"1.03E-02"},"PPP2CB.ACTB"]
["Leukocyte Extravasation Signaling",{"v":1.32,"d":"1.32E+00"},{"v":0.0098,"d":"9.80E-03"},"ACTB.ACTG1"]
["Cell Cycle Regulation by BTG Family Proteins",{"v":1.23,"d":"1.23E+00"},{"v":0.0286,"d":"2.86E-02"},"PPP2CB"]
["Glycolysis I",{"v":1.17,"d":"1.17E+00"},{"v":0.0244,"d":"2.44E-02"},"ENO1"]
["Retinol Biosynthesis",{"v":1.15,"d":"1.15E+00"},{"v":0.0233,"d":"2.33E-02"},"ESD"]
["Gluconeogenesis I",{"v":1.12,"d":"1.12E+00"},{"v":0.0217,"d":"2.17E-02"},"ENO1"]
["Xenobiotic Metabolism Signaling",{"v":1.09,"d":"1.09E+00"},{"v":0.00725,"d":"7.25E-03"},"PPP2CB.ESD"]
["Mitotic Roles of Polo-Like Kinase",{"v":0.97,"d":"9.70E-01"},{"v":0.0152,"d":"1.52E-02"},"PPP2CB"]
["Role of BRCA1 in DNA Damage Response",{"v":0.902,"d":"9.02E-01"},{"v":0.0128,"d":"1.28E-02"},"ACTB"]
["Cyclins and Cell Cycle Regulation",{"v":0.902,"d":"9.02E-01"},{"v":0.0128,"d":"1.28E-02"},"PPP2CB"]
["Ceramide Signaling",{"v":0.872,"d":"8.72E-01"},{"v":0.0119,"d":"1.19E-02"},"PPP2CB"]
["HIPPO signaling",{"v":0.857,"d":"8.57E-01"},{"v":0.0115,"d":"1.15E-02"},"PPP2CB"]
["CTLA4 Signaling in Cytotoxic T Lymphocytes",{"v":0.853,"d":"8.53E-01"},{"v":0.0114,"d":"1.14E-02"},"PPP2CB"]
["TR/RXR Activation",{"v":0.835,"d":"8.35E-01"},{"v":0.0109,"d":"1.09E-02"},"ENO1"]
["Dopamine Receptor Signaling",{"v":0.835,"d":"8.35E-01"},{"v":0.0109,"d":"1.09E-02"},"PPP2CB"]
["p53 Signaling",{"v":0.81,"d":"8.10E-01"},{"v":0.0102,"d":"1.02E-02"},"PCNA"]
["Telomerase Signaling",{"v":0.806,"d":"8.06E-01"},{"v":0.0101,"d":"1.01E-02"},"PPP2CB"]
["CDK5 Signaling",{"v":0.79,"d":"7.90E-01"},{"v":0.00971,"d":"9.71E-03"},"PPP2CB"]
["HIF1α Signaling",{"v":0.786,"d":"7.86E-01"},{"v":0.00962,"d":"9.62E-03"},"LDHB"]
["Amyotrophic Lateral Sclerosis Signaling",{"v":0.775,"d":"7.75E-01"},{"v":0.00935,"d":"9.35E-03"},"SSR4"]
["Type I Diabetes Mellitus Signaling",{"v":0.76,"d":"7.60E-01"},{"v":0.00901,"d":"9.01E-03"},"HSPD1"]
["Oxidative Phosphorylation",{"v":0.733,"d":"7.33E-01"},{"v":0.0084,"d":"8.40E-03"},"ATP5B"]
["p70S6K Signaling",{"v":0.713,"d":"7.13E-01"},"8E-03","PPP2CB"]
["Atherosclerosis Signaling",{"v":0.713,"d":"7.13E-01"},"8E-03","ALB"]
["LXR/RXR Activation",{"v":0.704,"d":"7.04E-01"},{"v":0.00781,"d":"7.81E-03"},"ALB"]
["PI3K/AKT Signaling",{"v":0.704,"d":"7.04E-01"},{"v":0.00781,"d":"7.81E-03"},"PPP2CB"]
["Hereditary Breast Cancer Signaling",{"v":0.695,"d":"6.95E-01"},{"v":0.00763,"d":"7.63E-03"},"ACTB"]
["FXR/RXR Activation",{"v":0.678,"d":"6.78E-01"},{"v":0.0073,"d":"7.30E-03"},"ALB"]
["IL-12 Signaling and Production in Macrophages",{"v":0.678,"d":"6.78E-01"},{"v":0.0073,"d":"7.30E-03"},"ALB"]
["Cardiac β-adrenergic Signaling",{"v":0.667,"d":"6.67E-01"},{"v":0.00709,"d":"7.09E-03"},"PPP2CB"]
["Regulation of eIF4 and p70S6K Signaling",{"v":0.643,"d":"6.43E-01"},{"v":0.00667,"d":"6.67E-03"},"PPP2CB"]
["Synaptic Long Term Depression",{"v":0.641,"d":"6.41E-01"},{"v":0.00662,"d":"6.62E-03"},"PPP2CB"]
["Aldosterone Signaling in Epithelial Cells",{"v":0.614,"d":"6.14E-01"},{"v":0.00617,"d":"6.17E-03"},"HSPD1"]
["Wnt/β-catenin Signaling",{"v":0.596,"d":"5.96E-01"},{"v":0.00588,"d":"5.88E-03"},"PPP2CB"]
["Acute Phase Response Signaling",{"v":0.593,"d":"5.93E-01"},{"v":0.00585,"d":"5.85E-03"},"ALB"]
["Dopamine-DARPP32 Feedback in cAMP Signaling",{"v":0.585,"d":"5.85E-01"},{"v":0.00571,"d":"5.71E-03"},"PPP2CB"]
["Calcium Signaling",{"v":0.562,"d":"5.62E-01"},{"v":0.00538,"d":"5.38E-03"},"TPM2"]
["Mitochondrial Dysfunction",{"v":0.558,"d":"5.58E-01"},{"v":0.00532,"d":"5.32E-03"},"ATP5B"]
["ERK/MAPK Signaling",{"v":0.552,"d":"5.52E-01"},{"v":0.00524,"d":"5.24E-03"},"PPP2CB"]
["mTOR Signaling",{"v":0.549,"d":"5.49E-01"},{"v":0.00518,"d":"5.18E-03"},"PPP2CB"]
["RAR Activation",{"v":0.541,"d":"5.41E-01"},{"v":0.00508,"d":"5.08E-03"},"ACTB"]
["Huntington's Disease Signaling",{"v":0.477,"d":"4.77E-01"},{"v":0.00426,"d":"4.26E-03"},"ATP5B"]
["Glucocorticoid Receptor Signaling",{"v":0.415,"d":"4.15E-01"},{"v":0.00356,"d":"3.56E-03"},"ACTB"]

{"sheet":"Functions and disease","index":1,"n_rows":73,"n_cols":3,"rows_kept":73,"flags":["formulas_cached_only"]}
["© 2000-2016 QIAGEN. All rights reserved."]
["Category"," p-value","Molecules"]
["Skeletal and Muscular Disorders","6.99E-08-4.48E-02","STMN1,ENO1,PCNA,ALB,CAPZB,ACTB,VIM,HSPD1,TPM2,ACTG1,ARHGDIB,LDHB,PRDX2"]
["Cellular Assembly and Organization","1.62E-07-4.85E-02","ACTR2,SRI,CAPZB,ACTB,VIM,HSPD1,TPM2,TUBB,ARHGDIB,STMN1,PPP2CB,ALB,PITPNA,ARPC2,CORO1A,ACTG1,WDR1"]
["Cellular Function and Maintenance","1.62E-07-4.85E-02","TUFM,SRI,ACTR2,CAPZB,PSMB10,ACTB,CLIC1,VIM,HBA1/HBA2,HSPD1,TPM2,TUBB,ARHGDIB,EEF1D,STMN1,ENO1,PCNA,ALB,PITPNA,ARPC2,CORO1A,ACTG1,WDR1,PRDX2"]
["Cellular Movement","4.65E-07-4.94E-02","STMN1,ACTR2,ENO1,ALB,ACTB,ARPC2,CORO1A,VIM,HSPD1,TUBB,ARHGDIB,PRDX2"]
["Immunological Disease","4.65E-07-4.61E-02","CAPZB,PSMB10,ACTB,VIM,HSPD1,HBA1/HBA2,TUBB,TPM2,ARHGDIB,LDHB,ESD,ENO1,ALB,PCNA,CORO1A,ACTG1,PRDX2"]
["Inflammatory Disease","4.65E-07-4.69E-02","ACTB,VIM,HBA1/HBA2,HSPD1,TPM2,TUBB,LDHB,ARHGDIB,ENO1,ALB,PITPNA,PRDX2,WDR1"]
["Inflammatory Response","4.65E-07-4.69E-02","CAPZB,ACTB,CLIC1,VIM,HBA1/HBA2,HSPD1,TPM2,TUBB,ARHGDIB,LDHB,ENO1,ALB,CORO1A,ACTG1,PRDX2"]
["Tissue Development","2.77E-06-4.44E-02","ACTR2,SRI,CAPZB,PSMB10,ACTB,CLIC1,VIM,TPM2,TUBB,EEF1D,STMN1,ALB,PCNA,ATP5B,ARPC2,CORO1A,ACTG1,PRDX2,WDR1"]
["Connective Tissue Disorders","2.86E-06-2.54E-02","ENO1,PCNA,ALB,ACTB,VIM,HSPD1,HBA1/HBA2,TPM2,ACTG1,ARHGDIB,LDHB,PRDX2"]
["Developmental Disorder","2.86E-06-2.54E-02","PCNA,ALB,ACTB,VIM,HBA1/HBA2,TPM2,TUBB,ACTG1,LDHB"]
["Organismal Injury and Abnormalities","2.86E-06-4.69E-02","TUFM,SRI,PSMB10,CLIC1,HBA1/HBA2,TUBB,TPM2,EEF1D,LDHB,STMN1,CNDP2,PITPNA,ZNF623,WDR1,ACTR2,HNRNPF,CAPZB,ACTB,VIM,HSPD1,GALM,PPA1,ARHGDIB,ESD,PPP2CB,ENO1,PCNA,ALB,ATP5B,HNRNPH1,ARPC2,CORO1A,HNRNPH3,ACTG1,ACTR1A,PRDX2"]
["Connective Tissue Development and Function","5.97E-05-3.61E-02","STMN1,ACTR2,ARPC2,ACTB,VIM,HBA1/HBA2,EEF1D,PRDX2"]
["Cell Morphology","7.95E-05-4.69E-02","TUFM,ACTR2,CAPZB,PSMB10,CLIC1,ACTB,VIM,HBA1/HBA2,HSPD1,STMN1,PPP2CB,PCNA,ALB,PITPNA,ARPC2,CORO1A,PRDX2"]
["Cell-To-Cell Signaling and Interaction","7.95E-05-3.84E-02","STMN1,ACTR2,ALB,CAPZB,PSMB10,ARPC2,ACTB,CLIC1,CORO1A,VIM,HSPD1,ACTG1,PRDX2"]
["Lymphoid Tissue Structure and Development","3.37E-04-4.44E-02","PSMB10,CORO1A,EEF1D,ARHGDIB,PRDX2"]
["Organ Morphology","3.37E-04-4.85E-02","ALB,CAPZB,PSMB10,PITPNA,CORO1A,VIM,HBA1/HBA2,EEF1D,ARHGDIB,PRDX2"]
["Free Radical Scavenging","9.05E-04-2.21E-02","ALB,ACTB,CLIC1,HBA1/HBA2,ARHGDIB,PRDX2"]
["RNA Post-Transcriptional Modification","9.05E-04-4.85E-02","HNRNPF,ALB,HNRNPH1,HNRNPH3"]
["Cellular Growth and Proliferation","9.78E-04-4.2E-02","HNRNPF,CAPZB,PSMB10,ACTB,CLIC1,VIM,HBA1/HBA2,HSPD1,TUBB,EEF1D,ARHGDIB,STMN1,ENO1,PCNA,ALB,ATP5B,PITPNA,CORO1A,ACTG1,PRDX2,WDR1"]
["Cellular Compromise","1.22E-03-4.69E-02","STMN1,ALB,CORO1A,VIM,TUBB,WDR1"]
["Infectious Diseases","1.44E-03-3.87E-02","HNRNPF,ACTR2,ALB,HNRNPH1,ATP5B,ACTB,HBA1/HBA2,HSPD1,TUBB,ARHGDIB,PRDX2"]
["Nucleic Acid Metabolism","1.59E-03-3.54E-02","STMN1,ENO1,PCNA,ATP5B,HSPD1,PPA1,ARHGDIB"]
["Embryonic Development","1.71E-03-4.44E-02","TUFM,SRI,ENO1,ALB,PCNA,CAPZB,PSMB10,VIM,ACTG1,EEF1D,PRDX2,WDR1"]
["Organ Development","1.71E-03-4.44E-02","STMN1,SRI,PCNA,ALB,CAPZB,PSMB10,VIM,HBA1/HBA2,ACTG1,EEF1D,PRDX2,WDR1"]
["Organismal Development","1.71E-03-4.85E-02","SRI,CAPZB,PSMB10,ACTB,VIM,HBA1/HBA2,EEF1D,ARHGDIB,PCNA,ALB,PITPNA,ACTG1,WDR1,PRDX2"]
["Skeletal and Muscular System Development and Function","1.71E-03-4.2E-02","STMN1,SRI,CAPZB,ATP5B,CLIC1,VIM,ACTG1,WDR1"]
["Amino Acid Metabolism","1.71E-03-1.02E-02","CNDP2,ALB"]
["Carbohydrate Metabolism","1.71E-03-4.69E-02","PITPNA,PPA1,GALM"]
["Cardiovascular Disease","1.71E-03-3.58E-02","PCNA,ALB,VIM,HSPD1,HBA1/HBA2,ARHGDIB,PRDX2"]
["Cardiovascular System Development and Function","1.71E-03-4.69E-02","ALB,CAPZB,VIM,HSPD1,HBA1/HBA2,ACTG1,PRDX2,WDR1"]
["Cellular Response to Therapeutics","1.71E-03-3.54E-02","PCNA,ACTG1,PRDX2"]
["DNA Replication, Recombination, and Repair","1.71E-03-3.37E-02","STMN1,PCNA,VIM,HSPD1"]
["Drug Metabolism","1.71E-03-8.54E-03","STMN1,ALB"]
["Endocrine System Disorders","1.71E-03-3.37E-02","STMN1,ENO1,ACTR2,ALB,CLIC1,VIM,TPM2,TUBB,ACTG1,EEF1D,PRDX2"]
["Energy Production","1.71E-03-3.54E-02","ENO1,PCNA,ALB,ATP5B,HSPD1"]
["Gastrointestinal Disease","1.71E-03-4.69E-02","TUFM,SRI,CLIC1,HBA1/HBA2,TUBB,TPM2,EEF1D,STMN1,CNDP2,PITPNA,WDR1,ACTR2,HNRNPF,CAPZB,ACTB,VIM,HSPD1,GALM,PPA1,ESD,ENO1,PPP2CB,PCNA,ALB,ATP5B,HNRNPH1,CORO1A,ACTG1,HNRNPH3,ACTR1A,PRDX2"]
["Hepatic System Disease","1.71E-03-2.54E-02","ALB,VIM,HBA1/HBA2"]
["Lipid Metabolism","1.71E-03-4.85E-02","STMN1,ALB,PITPNA,VIM,PRDX2"]
["Molecular Transport","1.71E-03-4.85E-02","STMN1,SRI,ENO1,ALB,ATP5B,PITPNA,CLIC1,CORO1A,VIM,HBA1/HBA2"]
["Post-Translational Modification","1.71E-03-3.7E-02","ALB,CAPZB,CORO1A,HSPD1"]
["Renal and Urological Disease","1.71E-03-4.2E-02","STMN1,ALB,PCNA,HNRNPH1,ARPC2,HBA1/HBA2,TUBB,PRDX2"]
["Tissue Morphology","1.71E-03-4.85E-02","STMN1,ENO1,CAPZB,PSMB10,PITPNA,CORO1A,VIM,HSPD1,HBA1/HBA2,EEF1D,ARHGDIB,PRDX2"]
["Tumor Morphology","1.71E-03-3.37E-02","STMN1,VIM,EEF1D"]
["Reproductive System Disease","1.92E-03-3.87E-02","ACTR2,HNRNPF,CLIC1,VIM,HBA1/HBA2,HSPD1,TUBB,TPM2,EEF1D,ARHGDIB,STMN1,ENO1,CNDP2,PCNA,ALB,HNRNPH1,PITPNA,ZNF623,ACTG1,WDR1"]
["Cellular Development","2.7E-03-4.2E-02","CAPZB,PSMB10,CLIC1,ACTB,VIM,HSPD1,ARHGDIB,STMN1,ALB,ATP5B,CORO1A,ACTG1,PRDX2,WDR1"]
["Hematopoiesis","2.76E-03-2.71E-02","CORO1A,HBA1/HBA2,ARHGDIB,EEF1D,PRDX2"]
["Cell Cycle","3.42E-03-4.2E-02","STMN1,PPP2CB,ACTR2,PCNA,VIM,TUBB"]
["Dermatological Diseases and Conditions","3.42E-03-4.41E-02","PCNA,ALB,PSMB10,VIM,TUBB,ARHGDIB"]
["Digestive System Development and Function","3.42E-03-4.85E-02","ALB,PITPNA,VIM,HBA1/HBA2"]
["Gene Expression","3.42E-03-4.69E-02","SRI,ALB,PCNA"]
["Hair and Skin Development and Function","3.42E-03-4.69E-02","TUFM,ENO1,PSMB10,VIM"]
["Nervous System Development and Function","3.42E-03-3.04E-02","STMN1,ALB,PITPNA,ACTB,VIM"]
["Visual System Development and Function","3.42E-03-3.42E-03","PSMB10"]
["Protein Synthesis","3.46E-03-4.74E-02","ALB,CAPZB,PITPNA,ARPC2,CORO1A,HBA1/HBA2,ARHGDIB"]
["Hepatic System Development and Function","6.84E-03-1.06E-02","ALB,PITPNA,HBA1/HBA2"]
["Organismal Functions","8.54E-03-3.04E-02","PSMB10,VIM"]
["RNA Trafficking","8.54E-03-8.54E-03","ALB"]
["Cell Signaling","1.19E-02-3.07E-02","STMN1,SRI,CAPZB,CORO1A"]
["Immune Cell Trafficking","1.19E-02-3.84E-02","CORO1A,HSPD1,PRDX2"]
["Nutritional Disease","1.19E-02-1.53E-02","ALB,PRDX2"]
["Renal and Urological System Development and Function","1.19E-02-4.53E-02","TUFM,STMN1,ENO1,VIM"]
["Humoral Immune Response","1.36E-02-1.36E-02","HSPD1"]
["Behavior","1.7E-02-1.7E-02","HBA1/HBA2"]
["Reproductive System Development and Function","1.87E-02-2.46E-02","ALB,PCNA"]
["Protein Trafficking","2.37E-02-2.37E-02","SRI"]
["Endocrine System Development and Function","3.04E-02-4.53E-02","PITPNA,VIM"]
["Vitamin and Mineral Metabolism","3.04E-02-3.07E-02","SRI,CORO1A,VIM"]
["Hypersensitivity Response","3.1E-02-3.7E-02","ALB,CORO1A"]
["Auditory and Vestibular System Development and Function","3.43E-02-3.43E-02","ACTG1,WDR1"]
["Protein Folding","3.7E-02-3.7E-02","HSPD1"]
["Cell-mediated Immune Response","3.91E-02-3.91E-02","CORO1A,HSPD1,EEF1D,PRDX2"]

{"sheet":"Specific functions","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"hidden":true,"flags":["formulas_cached_only"]}

{"sheet":"Tox functions","index":3,"n_rows":0,"n_cols":0,"rows_kept":0,"hidden":true,"flags":["formulas_cached_only"]}

{"sheet":"Networks","index":4,"n_rows":0,"n_cols":0,"rows_kept":0,"hidden":true,"flags":["formulas_cached_only"]}